GlassScriptPhysician profile
Daniel M Goldman
NPI 1417950767
$725.38
in general payments reported to CMS, 2019-2025
12 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $53.76 · 2023: $60.42 · 2024: $372 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $671.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $124.99 | 2024 | Epclusa |
| Merck Sharp & Dohme LLC | $124.09 | 2025 | Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.06 | 2024 | Jardiance |
| Pfizer INC. | $78.28 | 2023-2024 | |
| Exact Sciences Corporation | $58.07 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Janssen Pharmaceuticals, INC | $56.57 | 2024-2025 | Spravato |
| Vbi Vaccine (Delaware) INC. | $39.52 | 2022-2023 | Prehevbrio |
| Stryker Corporation | $35.37 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Inspire Medical Systems, INC. | $30.20 | 2024 | Inspire |
| Genentech USA, INC. | $27.78 | 2022 | |
| Modernatx, INC. | $16.29 | 2024 | Moderna Covid-19 Vaccine |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.16 | 2024 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Goldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.